列线图预测前列腺癌患者的预后:基于蛋白组学的研究
A Nomogram for Predicting the Prognosis of Patients in Prostate Cancer: Research Based on Proteomics
DOI: 10.12677/jcpm.2024.34349, PDF,    科研立项经费支持
作者: 杨 磊, 张志强*:安徽医科大学第二附属医院泌尿外科,安徽 合肥
关键词: 前列腺癌蛋白组学TCGA数据库预后模型风险评分Prostate Cancer Proteomics TCGA Database Prognostic Model Risk Score
摘要: 前列腺癌是男性最常见且致命的恶性肿瘤之一,具有较高的发病率和死亡率。本研究利用TCGA数据库蛋白质组学数据,采用生物信息学方法利用蛋白组学构建前列腺癌预后模型。通过COX回归分析确定了关键的蛋白质,并利用它们构建了风险评分模型。通过Kaplan-Mier曲线和ROC曲线等多种方法验证了该模型的预测性能。结果表明,模型能够有效地将前列腺癌患者分为高风险组和低风险组,具有很强的预后准确性。本研究为前列腺癌的精准医疗提供了理论依据,并为临床个性化治疗提供了新的方向。
Abstract: Prostate cancer is one of the most common and lethal malignant tumors in men, which has a high incidence and mortality rate. This study leverages proteomics data from the TCGA database and applies bioinformatics methods to build a protein expression prognostic model for prostate cancer. Key protein markers were identified COX regression analysis, and a risk scoring model was constructed based on these key proteins. The model’s predictive performance was verified by various methods, including Kaplan-Mier Curve and ROC Curve. The results demonstrate that this model can effectively distinguish between high-risk and low-risk groups of patients about prostate cancer with strong prognostic accuracy. This study provides a theoretical basis for precision medicine in prostate cancer and offers a new direction for clinical personalized treatment.
文章引用:杨磊, 张志强. 列线图预测前列腺癌患者的预后:基于蛋白组学的研究[J]. 临床个性化医学, 2024, 3(4): 2445-2454. https://doi.org/10.12677/jcpm.2024.34349

参考文献

[1] Bergengren, O., Pekala, K.R., Matsoukas, K., Fainberg, J., Mungovan, S.F., Bratt, O., et al. (2023) 2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review. European Urology, 84, 191-206. [Google Scholar] [CrossRef] [PubMed]
[2] Sun, D., Li, H., Cao, M., He, S., Lei, L., Peng, J., et al. (2020) Cancer Burden in China: Trends, Risk Factors and Prevention. Cancer Biology and Medicine, 17, 879-895. [Google Scholar] [CrossRef] [PubMed]
[3] Wang, Y., Yan, Q., Fan, C., Mo, Y., Wang, Y., Li, X., et al. (2023) Overview and Countermeasures of Cancer Burden in China. Science China Life Sciences, 66, 2515-2526. [Google Scholar] [CrossRef] [PubMed]
[4] Gurevich, V.V. (2019) Protein Multi-Functionality: Introduction. Cellular and Molecular Life Sciences, 76, 4405-4406. [Google Scholar] [CrossRef] [PubMed]
[5] Tomczak, K., Czerwińska, P. and Wiznerowicz, M. (2015) Review the Cancer Genome Atlas (TCGA): An Immeasurable Source of Knowledge. Współczesna Onkologia, 1, 68-77. [Google Scholar] [CrossRef] [PubMed]
[6] Jang, J.H. (2021) Principal Component Analysis of Hybrid Functional and Vector Data. Statistics in Medicine, 40, 5152-5173. [Google Scholar] [CrossRef] [PubMed]
[7] In, J. and Lee, D.K. (2019) Survival Analysis: Part II—Applied Clinical Data Analysis. Korean Journal of Anesthesiology, 72, 441-457. [Google Scholar] [CrossRef] [PubMed]
[8] Gomes, A.P., Costa, B., Marques, R., Nunes, V. and Coelho, C. (2024) Kaplan-Meier Survival Analysis: Practical Insights for Clinicians. Acta Médica Portuguesa, 37, 280-285. [Google Scholar] [CrossRef] [PubMed]
[9] Su, C., Xue, J. and Liu, N. (2023) Cox Regression Analysis of Prognostic Factors of Intensity-Modulated Radiotherapy in Patients with Bladder Cancer. Archivos Españoles de Urología, 76, 411-417. [Google Scholar] [CrossRef] [PubMed]
[10] Hoo, Z.H., Candlish, J. and Teare, D. (2017) What Is an ROC Curve? Emergency Medicine Journal, 34, 357-359. [Google Scholar] [CrossRef] [PubMed]
[11] Zhang, W., Ji, L., Wang, X., Zhu, S., Luo, J., Zhang, Y., et al. (2022) Nomogram Predicts Risk and Prognostic Factors for Bone Metastasis of Pancreatic Cancer: A Population-Based Analysis. Frontiers in Endocrinology, 12, Article 752716. [Google Scholar] [CrossRef] [PubMed]